Dr. Ivan Foster Ackerman , MD
Internal Medicine - Pulmonary Disease • Brandon, FL
402 Noland Dr
Brandon, FL 335115709
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Ivan Ackerman is listed in NPPES under Internal Medicine - Pulmonary Disease.
-
NPI assigned on March 28, 2006; this date does not establish years in practice.
-
Published CMS data list 2,645 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 1,249 service units.
- 94618 — Test for exercise-induced lung stress: 281 service units.
- 94060 — Test to measure expiratory airflow and volume changes before and after medication administration: 276 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 12 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 6,298 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Albuterol Sulfate Hfa (Albuterol Sulfate) — 1,653 prescription fills, including refills.
- Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) — 985 prescription fills, including refills.
- Prednisone — 469 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 55 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 75% of clinicians listed under Internal Medicine - Pulmonary Disease in Florida (2024, 758 clinicians with data). Median for this group: 1,153. Middle half: 462 to 2,578.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,681 in 2020 to 2,645 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
402 Noland Dr
Brandon, FL 335115709
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Tampa Bay Pulmonary Medicine, Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Central Del Caribe Escuela De Medicina
1981
What Public CMS Data Show
Internal Medicine - Pulmonary Disease: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
755 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $261,212 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $196,014 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
8,746 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,008,252 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $870.53 across 30 records.
By nature of payment
- Food and Beverage: $819.15 across 28 records.
- Education: $51.38 across 2 records.
Reporting-company totals (3 largest of 15)
- Inspire Medical Systems, Inc.: $187.08 across 1 record.
- GlaxoSmithKline, LLC.: $152.48 across 7 records.
- Insmed, Inc.: $104.48 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
45 years (graduated 1981)
CMS Doctors and Clinicians data list 1981 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ackerman has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ackerman as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Brandon and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 75% of clinicians listed under Internal Medicine - Pulmonary Disease in Florida (2024, 758 clinicians with data). Median for this group: 1,153. Middle half: 462 to 2,578.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Brandon have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Pulmonary Disease in Florida (2024, 758 clinicians with data). Median for this group: $127,001. Middle half: $54,793 to $253,788.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Brandon have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 75% of clinicians listed under Internal Medicine - Pulmonary Disease in Florida (2024, 758 clinicians with data). Median for this group: $99,078. Middle half: $42,294 to $195,595.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Brandon have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Florida (2024, 688 clinicians with data). Median for this group: 916. Middle half: 266 to 2,096.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Brandon have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Pulmonary Disease in Florida (2024, 688 clinicians with data). Median for this group: $506,337. Middle half: $108,198 to $1,139,495.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Brandon have Medicare Part D data for 2024 to compare.
13 active clinicians are listed under Internal Medicine - Pulmonary Disease with a practice address in Brandon, FL (1,045 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Brandon
23.1% of these 13 clinicians have the CMS telehealth indicator.
61.5% of these 13 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 28% from 3,681 in 2020 to 2,645 in 2024.
- 2020: 3,681
- 2021: 3,135
- 2022: 2,857
- 2023: 2,700
- 2024: 2,645
-
Medicare-allowed amount
Medicare-allowed amount decreased 27% from $357,763 in 2020 to $261,212 in 2024.
- 2020: $357,763
- 2021: $319,091
- 2022: $285,887
- 2023: $260,277
- 2024: $261,212
-
Paid by Medicare
Paid by Medicare decreased 26% from $265,884 in 2020 to $196,014 in 2024.
- 2020: $265,884
- 2021: $237,851
- 2022: $208,924
- 2023: $190,658
- 2024: $196,014
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 6,057 in 2020 and 6,298 in 2024.
- 2020: 6,057
- 2021: 6,589
- 2022: 6,405
- 2023: 6,131
- 2024: 6,298
-
30-day fills
30-day fills stayed about the same: 8,640 in 2020 and 8,746 in 2024.
- 2020: 8,640
- 2021: 9,205
- 2022: 9,024
- 2023: 8,605
- 2024: 8,746
-
Part D drug cost
Part D drug cost increased 19% from $2,536,933 in 2020 to $3,008,252 in 2024.
- 2020: $2,536,933
- 2021: $3,448,924
- 2022: $3,313,642
- 2023: $3,160,900
- 2024: $3,008,252
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 94% from $14,818.30 in 2021 to $870.53 in 2025.
- 2021: $14,818.30
- 2022: $10,815.91
- 2023: $10,358.79
- 2024: $1,337.79
- 2025: $870.53
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 30 records totaling $870.53.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Inspire Medical Systems, Inc. |
Food and Beverage
In-kind items and services
|
INSPIRE | General | $187.08 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $34.32 |
| Amgen Inc. |
Education
In-kind items and services
|
— | General | $34.00 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $30.01 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $29.89 |
| HARMONY BIOSCIENCES LLC |
Food and Beverage
In-kind items and services
|
WAKIX | General | $29.63 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $27.41 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $27.20 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $26.26 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $25.63 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
ZEPBOUND | General | $25.36 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $25.21 |
| Azurity Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ALVESCO | General | $24.98 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $24.62 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $23.92 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $22.81 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $22.01 |
| Inogen, Inc. |
Food and Beverage
Cash or cash equivalent
|
INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH | General | $21.98 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $21.76 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $21.63 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $21.39 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $20.97 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $20.32 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $19.12 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $18.58 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,249 | 628 | $150.00 | $124.04 |
|
94618
Test for exercise-induced lung stress
|
281 | 277 | $100.00 | $32.66 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
276 | 275 | $100.00 | $36.53 |
|
94729
Test to examine how well the lungs exchange gases
|
274 | 273 | $100.00 | $52.74 |
|
94726
Test to determine lung volumes using sensors
|
239 | 238 | $100.00 | $52.39 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
114 | 96 | $110.00 | $88.19 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
62 | 62 | $225.00 | $163.55 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
55 | 55 | $150.00 | $108.77 |
|
95810
Sleep study in sleep lab (6 years or older)
|
32 | 32 | $900.00 | $583.56 |
|
94727
Test to determine lung volumes using gas dilution or washout
|
29 | 29 | $100.00 | $42.10 |
|
95811
Sleep study in sleep lab with continuous airway pressure (6 years or older)
|
21 | 21 | $1000.00 | $610.61 |
|
G0399
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation
|
13 | 13 | $275.00 | $89.30 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Albuterol Sulfate Hfa | Albuterol Sulfate | 1,653 | 58,038 | $50,168.78 | 560 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 985 | 39,540 | $824,860.48 | 240 |
| Prednisone | Prednisone | 469 | 10,785 | $1,454.27 | 223 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 254 | 12,180 | $35,624.48 | 106 |
| Symbicort | Budesonide/Formoterol Fumarate | 251 | 10,746 | $79,845.56 | 91 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 247 | 9,690 | $196,236.50 | 73 |
| Montelukast Sodium | Montelukast Sodium | 212 | 17,013 | $1,937.36 | 72 |
| Spiriva Respimat | Tiotropium Bromide | 205 | 8,880 | $153,191.39 | 48 |
| Ventolin Hfa | Albuterol Sulfate | 179 | 6,378 | $12,690.28 | 63 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 159 | 6,240 | $67,260.41 | 44 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 131 | 5,430 | $14,473.86 | 52 |
| Azithromycin | Azithromycin | 114 | 625 | $379.28 | 93 |
| Spiriva Handihaler | Tiotropium Bromide | 83 | 4,170 | $69,898.65 | 31 |
| Breo Ellipta | Fluticasone/Vilanterol | 81 | 3,810 | $49,594.55 | 29 |
| Breyna | Budesonide/Formoterol Fumarate | 70 | 2,917 | $12,713.41 | 30 |
| Trazodone Hcl | Trazodone Hcl | 65 | 4,410 | $898.92 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 59 | 3,300 | $738.21 | 24 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 59 | 2,520 | $39,318.19 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 57 | 1,830 | $20,405.69 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 394 | $400.89 | 51 |
| Cefdinir | Cefdinir | 50 | 351 | $595.57 | 45 |
| Eliquis | Apixaban | 49 | 2,022 | $39,003.70 | 13 |
| Levofloxacin | Levofloxacin | 42 | 231 | $220.31 | 38 |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 42 | 1,955 | $3,476.30 | 20 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 42 | 1,560 | $7,048.27 | 22 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207RP1001X
An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PULMONARY DISEASE
I20100803001103
FL
4486606845
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Tampa Bay Pulmonary Medicine, Pa
402 Noland Dr, Brandon, FL 335115709
Phone: 8136552500
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Gerontology
Career & Practice History
NPI enumerated March 28, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine - Pulmonary Diseases in Brandon
- Dr. Arthur Graves, MD
- Dr. Richard England, MD
- Ankur Aneja
- Dr. Jonathan Axel, MD
- Dr. Rakesh Shah, MD
- Dr. Daniel Lorch, MD
Mailing Address
402 Noland Dr
Brandon, FL 335115709
Phone: 8136559000